Congratulations on the launch! Would love to know (1) what’s the science like supporting this and (2) as a startup how do you guarantee the stems cells will still be around in 10/50 years?
Most notably, I like to point out that banking over donating is what we advocate for because using a donor's hematopoietic stem cells risks rejection and even fatality, so using a genetically related (or your own) stem cells increases your chances of survival (https://www.nejm.org/doi/full/10.1056/nejm199708073370602)
As a startup, we have a legal obligation to ensure that the CRM is handed off in case anything happens to the company. Our lab has been around for over 40 years processing different kinds of blood products, so they are definitely not going anywhere (and the blood products our clients stored wouldn't either), and they would simply communicate with a new CRM.